BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26059307)

  • 1. [Hepatitis B vaccination: a review].
    Launay O; Floret D
    Med Sci (Paris); 2015 May; 31(5):551-8. PubMed ID: 26059307
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis B vaccine and demyelinating diseases: debate and disinformation].
    Pol S
    Presse Med; 2009 Apr; 38(4):519-23. PubMed ID: 19201152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibodies against hepatitis B after vaccination in health workers].
    Pérez-López JA; García-Elorriaga G; Del Rey-Pineda G; Manjarrez-Téllez B
    Salud Publica Mex; 2011; 53(3):205-6. PubMed ID: 21829884
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination against hepatitis B. The 1988-1991 experience at Local Health District 9, Lombardy].
    Gariboldi G
    Ann Ig; 1993; 5(3):199-205. PubMed ID: 7513177
    [No Abstract]   [Full Text] [Related]  

  • 5. Continue to vaccinate against hepatitis B.
    Prescrire Int; 2009 Jun; 18(101):131. PubMed ID: 19637437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review.
    Demicheli V; Rivetti A; Di Pietrantonj C; Clements CJ; Jefferson T
    J Viral Hepat; 2003 Sep; 10(5):343-4. PubMed ID: 12969184
    [No Abstract]   [Full Text] [Related]  

  • 7. No increase in demyelinating diseases after hepatitis B vaccination.
    Zipp F; Weil JG; Einhäupl KM
    Nat Med; 1999 Sep; 5(9):964-5. PubMed ID: 10470051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adaptability of the anti-hepatitis-B vaccine Recombivax HB to the Piazza protocol for the mass vaccination of newborn infants].
    Piazza M; Abrescia N; Picciotto L; Cotugno M; Vegnente A; Iorio R; Cimmino L
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):483-9. PubMed ID: 1482565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B revaccination not indicated, even for those at increased risk].
    Isken LD; Zaaijer HL; van Steenbergen JE
    Ned Tijdschr Geneeskd; 2009; 153():A415. PubMed ID: 19900310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing strategies for hepatitis B vaccination.
    Alavian SM; Fallahian F; Lankarani KB
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):10-22. PubMed ID: 20061687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B: the incidence of carriers and the initial experience of mass vaccination in the police].
    Cioli S; Cordelli A; Sardone D; Giannelli G; Lalli CG; Maresca A; Pioda GB; Lanzetta BM; D'Annibali E
    G Ital Med Lav; 1990; 12(2-4):81-5; discussion 85-6. PubMed ID: 2152608
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic adverse effects of hepatitis B vaccines are rare.
    Prescrire Int; 2004 Dec; 13(74):218-23. PubMed ID: 15612143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host factors related to poor immunogenicity of hepatitis B vaccine in adults. Another reason to immunize early.
    Margolis HS; Presson AC
    JAMA; 1993 Dec 22-29; 270(24):2971-2. PubMed ID: 8254860
    [No Abstract]   [Full Text] [Related]  

  • 15. Current views on the persistence of immunity following hepatitis B vaccination.
    Madaliński K; Kołakowska A; Godzik P
    Przegl Epidemiol; 2015; 69(1):47-51, 147-50. PubMed ID: 25862447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.
    Tosti ME; Traversa G; Bianco E; Mele A
    Ital J Gastroenterol Hepatol; 1999; 31(5):388-91. PubMed ID: 10470598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel].
    Ricciardi G; Graziano G
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):385-90. PubMed ID: 2152297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against hepatitis B virus: current data].
    Zoulim F
    Med Trop (Mars); 1999; 59(4 Pt 2):503-7. PubMed ID: 10901855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against hepatitis B].
    Madaliński K; Mikołajewicz J; Michalska Z
    Przegl Epidemiol; 1996; 50(1-2):3-14. PubMed ID: 8711156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccination: time for a booster?
    Shopper T
    LDA J; 1992; 51(3):5-6. PubMed ID: 9518764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.